Proteomics Services Market: Market Size & Forecast 2026

Proteomics services encompass a range of offerings including protein sequencing, mass spectrometry-based analysis, biomarker discovery, and bioinformatics interpretation provided to academic institutions, pharmaceutical companies, and clinical laboratories. The market operates without official government-published size estimates, leading private research firms to serve as the primary source of market intelligence. Estimates for the narrower services segment in 2025 range from approximately $8.06 billion to $8.77 billion depending on the methodology and scope applied.

• •Services-focused market valued at approximately $8.3 billion in 2025; projected to reach $16.46 billion by 2030
• •No government agency publishes official standalone commercial figures for proteomics services
• •Market sizing depends on private research tracking and industry methodology variations

A primary driver of market expansion is the increasing trend among pharmaceutical and biotechnology companies to outsource complex R&D activities to specialized service providers, reducing in-house infrastructure costs while accessing advanced analytical capabilities. The growing integration of proteomics into clinical diagnostics, particularly for cancer biomarker identification and personalized medicine applications, is creating new demand streams. Additionally, advancements in mass spectrometry, chromatography, and artificial intelligence-driven bioinformatics tools are lowering technical barriers and expanding the scope of feasible research.

• •Outsourcing of biopharmaceutical R&D activities accelerating demand for specialized service providers
• •Clinical expansion, including cancer biomarker discovery and personalized medicine, broadening addressable market
• •Advances in mass spectrometry and AI-powered bioinformatics enabling more complex analyses at scale

The proteomics services market is commonly segmented by service type, including protein identification and quantification, protein purification, bioinformatics analysis, and antibody-based services. By application, key segments include drug discovery and development, clinical diagnostics, academic research, and biomarker discovery. North America dominates the broader proteomics landscape, with regional market size estimates around $14.11 billion in 2025 and a projected CAGR of approximately 12.7% through 2030, driven by significant pharmaceutical industry presence, strong academic research infrastructure, and favorable regulatory frameworks.

• •North America accounts for a substantial share of the broader proteomics market at roughly $14.11 billion in 2025
• •Services segments span protein analysis, bioinformatics, purification, and antibody-based applications across drug discovery, clinical diagnostics, and academic research
• •Regional growth varies based on pharmaceutical R&D intensity, academic infrastructure, and regulatory environment

What are the recent trends and outlook?

The market is expected to sustain a double-digit growth trajectory through 2030, supported by continued investment in antibody therapeutics, the rising importance of protein-based drug targets, and expanding clinical proteomics programs. AI and machine learning are increasingly integrated into proteomic data analysis pipelines, improving the speed and accuracy of protein characterization and biomarker identification. Single-cell proteomics and spatial proteomics represent emerging frontiers that are expected to drive new service demand, while the ongoing convergence of proteomics with genomics and metabolomics data will reinforce the central role of protein analysis in comprehensive biological research.

• •Projected CAGR of approximately 13% maintained through 2030 as pharma outsourcing and clinical applications grow
• •AI-enhanced bioinformatics and single-cell proteomics emerging as high-growth service categories
• •Integration of proteomics with multi-omics platforms expected to deepen cross-disciplinary demand